PO-1676: Blood biomarkers for cognitive damage after PCI; an exploratory analysis of the HA-PCI phase 3 trial.
Saved in:
| Title: | PO-1676: Blood biomarkers for cognitive damage after PCI; an exploratory analysis of the HA-PCI phase 3 trial. |
|---|---|
| Authors: | Compter, I. (AUTHOR), Oldoni, E. (AUTHOR), Houben, R. (AUTHOR), Van der Weijst, L. (AUTHOR), De Ruiter, M. (AUTHOR), Goris, A. (AUTHOR), Holt, M. (AUTHOR), Deprez, S. (AUTHOR), Lambrecht, M. (AUTHOR), Lievens, Y. (AUTHOR), Van Meerbeeck, J.P. (AUTHOR), Schagen, S.B. (AUTHOR), Belderbos, J.S.A. (AUTHOR), De Ruysscher, D.K.M. (AUTHOR) |
| Source: | Radiotherapy & Oncology. 2020 Supplement 1, Vol. 152, pS921-S922. 2p. |
| Subjects: | Biomarkers, Posters, Physics |
| Abstract: | Poster: Physics track: Quantitative functional and biological imaging PO-1676: Blood biomarkers for cognitive damage after PCI; an exploratory analysis of the HA-PCI phase 3 trial I. Compter, E. Oldoni, R. Houben, L. Van der Weijst, M. De Ruiter, A. Goris, M. Holt, S. Deprez, M. Lambrecht, Y. Lievens, J.P. Van Meerbeeck, S.B. Schagen, J.S.A. Belderbos, D.K.M. De Ruysscher. [Extracted from the article] |
| Copyright of Radiotherapy & Oncology is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Engineering Source |
Be the first to leave a comment!
